brain proteins was noted. This observation has now been confirmed on a larger series of animals (A H Bone & A N Davison, unpublished) and we have checked specific activities of the immediate precursor amino acid-soluble pool in the brain. High levels (20-60 mg/100 ml) of phenylalanine reduce brain protein synthesis by about 15 % of normal. Similar effects may be seen in other cases of amino acid imbalance (leucinosis, hyperprolinxvmia, homocystinuria, &c.) . It is suggested that continuous block of protein synthesiseven at this low levelwill have a permanent and deleterious effect on formation of essential brain structures. Thus, formation of synapses may be impaired or myelination be interrupted during the perinatal period, whereas little such effect would be seen intheadult human brain wherestructural synthesis is complete. Monoamines and Mental Disease Charles Darwin said: 'I have no faith in anything short of actual measurement and the rule of three.' But in the central nervous system, as elsewhere, arbitrary selection processes make a mock of objectivity; we choose to measure the things that are easy to measure and tend to forget those that are not. 5-hydroxytryptamine, for instance, by virtue of its 5-hydroxyl group, possesses a specific fluorescence in strong acid denied to its unhydroxylated analogue, tryptamine, and tryptamine (Martin et al. 1971 ) is an unknown quantity in the central nervous system; the catecholamines, with their two adjacent hydroxyl groups, adsorb conveniently on to alumina but the monophenolic phenylethylamines and -ethanolamines do not and, as a consequence, have a token literature only to represent them. Very recently, however, we have been in the throes of a methodological revolution and it is now possible to quantify accurately vast numbers of relatively undistinguished molecules. Whilst immunoassay procedures have yet to prove their usefulness for molecules as small as the monoamines, combined gas chromatography-mass spectrometry, perhaps with the additional refinement of mass fragmentography (Hammar et al. 1969) , is well suited to measure these compounds with accuracy and specificity. An information explosion appears to be inevitable! And yet it would be a pity for the pendulum to swing to the other extreme, and for the role of 5-hydroxytryptamine and the catecholamines to be submerged in a welter of new data; there is still much to implicate them in the pathogenesis of mental disorder (Himwich 1970) .
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The structural similarity of many hallucinogens to these monoamines, e.g. lysergide, bufotenine, psilocybin or harmaline to 5-hydroxytryptamine, mescaline or dimethoxyamphetamine to dopamine, has, by analogy, initiated a search for an endogenous psychotomimetic compound as the causative agent for schizophrenia. But all attempts to identify such a compound, whether as adrenochrome, dimethoxyphenylethylamine or many others, have so far met with scant success (Weil-Malherbe & Szara 1971) .
A hypothesis involving some disturbance at the level of the putative dopamine receptor, based on the similarity between some of the clinical features of schizophrenia and the pharmacological derangement (model psychosis) associated with amphetamine overdosage, at present holds the centre of the stage (e.g. Randrup & Munkvad 1967) . It is given flesh by the ability of such drugs as pimozide (Morris et al. 1970) , 'central dopamine receptor' blockers, to attenuate or alleviate the clinical features of schizophrenia. But there is no shortage of hypotheses: one of the most recent involves the endogenous generation of toxic concentrations of 6-hydroxydopamine (Stein & Wise 1971) .
The action of the various antidepressive drugs similarly appears to be modulated by alterations in monoamine function; perhaps the most impressive linking evidence is the profound lightening of affect brought about by monoamine oxidase inhibiting drugs in depressive patients. These drugs show great variation in their antidepressive action (Davis 1965) , perhaps reflecting their differing ability to inhibit a specific monoamine oxidase isoenzyme at a localized anatomical site (Sandler et al. 1971) . Such studies may eventually help to establish the identity and crucial concentration of the amine or amines indispensable to a normal mental state. With newer measuring techniques, the whole problem is likely to become more rather than less complex before its final solution. Dr Derek Richter (Neuropsychiatry Unit, MRCLaboratories, Woodmansterne Road, Carshalton, Surrey) Endocrine Factors Affecting the Maturation of the Brain Hormones affect the functional activity of the brain in a number of different ways. Adult behaviour is influenced reversibly by a deficiency or excess of thyroid hormone: it is influenced also by androgens or by treatment with adrenocortical preparations. Hormonal imbalance during the period of early growth and development can affect the pattern of neuronal organization of the brain and produce behavioural effects which are irreversible. Thyroid deficiency in early life leads to defective growth of the axons and dendrites of the nerve cells: it appears that thyroid hormone is needed for the differentiation of the neurones and hence for the development of the adult pattern of synaptic connexions in the brain (Eayrs 1968 ). Recent observations of Balazs and his colleagues have shown that thyroid deficiency delays the biochemical as well as the morphological maturation of the brain: thus thyroid deficiency during the postnatal period in the rat retards the development of the metabolic pattern and the metabolic compartmentation characteristic of the adult brain. Thyroid deficiency also decreases the average size of the neurones, as indicated by their content of protein and RNA, without greatly affecting the final cell number in the brain (Balazs et al. 1968 ). On the other hand administration of thyroid hormone (triiodothyronine) advances the morphological and biochemical maturation of the rat brain: it also leads to the premature termination of postnatal cell formation (as indicated by deposition of DNA) so that there is a significant reduction of 30-40% in the final number of cells. Glia and nerve cells are both affected. It appears that, by advancing the differentiation of the nerve cells, thyroid hormone promotes their migration from the germinating layer, and so causes a premature termination of cell division. This effect is especially marked in the cerebellum, which develops later than other parts of the brain.
Treatment with hydrocortisone in early life also results in a permanent decrease in the final cell number in the rat brain. The rates of synthesis and deposition of DNA are severely inhibited during the period of hydrocortisone administration; and active cell division ceases, as in the normal animal, at about 21 days (Balizs 1972) . The end result of treatment with hydrocortisone on cell number is thus similar to that of treatment with triiodothyronine. Eayrs (1968) has observed that early treatment with thyroid hormone causes a later impairment of adaptive behaviour in the adult. However, treatment with corticosteroids has been reported to interfere with later emotional stability and with motor co-ordination in the adult, while leaving adaptive behaviour unaffected (Schapiro 1968 ). Balazs (1972) has suggested that the functional impairment in the adult may be due to the alteration in organization associated with a reduction in the normal proportion of microneurones so that the normal 'wiring pattern' is altered in certain parts of the brain. The different effects produced by treatment with thyroid hormone and corticosteroids may be due to their acting at different sites or at different times during development, depending on the experimental conditions used. The effects of hormones on the biochemical maturation of the brain have been reviewed elsewhere (Balazs 1972 , Balazs & Richter 1972 .
